Triphenylphosphine → 5-{3-(3-(3-Hydroxy-2-methoxycarbonyl-phenoxy)-propyl)-phenyl}-isoxazole-3-carboxylic Acid
Reaction equation
C([O:3][C:4]([C:6]1[CH:10]=[C:9]([C:11]2[CH:16]=[CH:15][CH:14]=[C:13]([CH2:17][CH2:18][CH2:19][OH:20])[CH:12]=2)[O:8][N:7]=1)=[O:5])C.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[OH:40][C:41]1[CH:50]=[CH:49][CH:48]=[C:47](O)[C:42]=1[C:43]([O:45][CH3:46])=[O:44].CCOC(/N=N/C(OCC)=O)=O>C1COCC1>[OH:40][C:41]1[C:42]([C:43]([O:45][CH3:46])=[O:44])=[C:47]([CH:48]=[CH:49][CH:50]=1)[O:20][CH2:19][CH2:18][CH2:17][C:13]1[CH:12]=[C:11]([C:9]2[O:8][N:7]=[C:6]([C:4]([OH:3])=[O:5])[CH:10]=2)[CH:16]=[CH:15][CH:14]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To 5-(3-(3-hydroxy-propyl)-phenyl)-isoxazole-3-carboxylic acid ethyl ester (31 mg, 0.1 mmol) was added triphenylphosphine (29 mg, 0.11 mmol), methyl (2,6-dihydroxy)benzoate (20 mg, 0.12 mmol), then THF (1 mL). After the solids had dissolved, diethylazodicarboxylate (20 μL, 0.13 mmol) was added, and the reaction was stirred at ambient temperature for 1 hour. The reaction was concentrated in vacuo, and the residue was taken up in aqueous 2M NaOH (1 mL), along with enough methanol to make the solution homogeneous. After stirring for 10 minutes, the solvents were removed in vacuo, glacial acetic acid (4 drops)was added, and the product was purified by reverse phase HPLC, eluting with a acetonitrile/0.1% aq. trifluoroacetic acid gradient to provide the title compound (2.7 mg, 7%). 1H NMR (500 MHz, d6-DMSO) δ 9.94 (s, 1H), 7.79 (s, 1H), 7.76 (d, 1H, J=7.8 Hz), 7.46 (t, 1H, J=7.6 Hz), 7.37 (d, 1H, J=7.5 Hz), 7.34 (s, 1H), 7.15 (t, 1H, J=8.3 Hz), 6.49 (dd, 2H, J=2.8, 8.4 Hz), 3.95 (t, 2H, J=6.2 Hz), 3.79 (s, 3H), 2.78 (t, 2H, J=7.5 Hz), 2.01 (m, 2H); MS (ESI) m/z 398 (M+H), 415 (M+NH4).
Workup
- dissolutionAfter the solids had dissolved
- concentrationThe reaction was concentrated in vacuo
- stirringAfter stirring for 10 minutes
- customthe solvents were removed in vacuo, glacial acetic acid (4 drops)
- additionwas added
- customthe product was purified by reverse phase HPLC
- washeluting with a acetonitrile/0.1% aq. trifluoroacetic acid gradient
Sources & evidence
- ORD record
- ord-e5de3e5c7dff419e88fba206cb834224
- Source dataset
- uspto-grants-2007_01
- Patent number
- US07169797B2
Reaction notes
Loading…